Partner With US
Gene Therapy Immunogenicity unites leading decision makers from large pharma and biotechs to tackle and explore the key immunogenicity roadblocks facing end-to-end drug development.
Bringing together the who’s-who of gene therapy, this meeting allows you to connect with leading industry members to collaboratively overcome the field’s challenges and find improved solutions. Immunogenicity is perhaps THE greatest challenge currently facing gene therapy drug developers and they need the expertise of solution providers to help drive their candidates through the clinic and beyond.
- Showcase your expertise to leading organizations through our exhibition space
- Represent your company through the expert speaker faculty to deliver data-rich, case study content to the gene therapy community
- Create new connections and cement existing relationships with pioneers in the field
- Position yourself as the go-to provider in this rapidly evolving space
Want to discuss further? Get in touch for more information.